Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Prostate Cancer - OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Conjunctivitis - New research on conjunctivitis from Innsbruck Medical University summarized
HIV/AIDS - Investigators at Chulalongkorn University zero in on HIV/AIDS
Malaria - New malaria study findings have been reported by N. Chavain and co-researchers
Multiple Sclerosis - Investigators at University of Basel zero in on multiple sclerosis
Multiple Sclerosis - Studies conducted at University of Turin on multiple sclerosis recently published
Prostate Cancer - Report summarizes prostate cancer study findings from University of Toronto
Solid Cancer - Studies from Queen Elizabeth Hospital in the area of solid cancer described
Arthritis Therapy - Research reports on arthritis therapy from Trubion Pharmaceuticals provide new insights
Heart Attack Therapy - Findings from St. Luke's Episcopal Hospital in heart attack therapy reported
Leukemia Therapy - Data on leukemia therapy detailed by researchers at University Hospital
Oncology - New oncology findings from Odense University, Department of Nuclear Medicine published
Prostate Cancer Therapy - Findings from Federico II University provide new insights into prostate cancer therapy
Alzheimer Disease - Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development
Asthma - MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
Bioscience - Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
Bone Marrow Transplantation - Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
Cancer Vaccines - Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
Clinical Trial Research - Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
Clinical Trial Research - SemBioSys begins phase I/II trial of insulin produced in plant seeds
Clinical Trial Research - Tigermed Sets Up Subsidiary, Hunan Tigermed Xiangya Drug R&D Ltd (Tigermed Xiangya)
Hepatitis C Virus - ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
HIV/AIDS - GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
Hyperalgesia - TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects
Menopause - Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Myelofibrosis - S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis
Obesity and Diabetes - Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
Osteoarthritis - NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance
Prostate Cancer - Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Pulmonary Disease - Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411
Sickle Cell Anemia - BioMarin uses Itamar Medical's Endo-PAT2000 in successful Phase 2 study for new treatment for Sickle Cell Disease
Sjogren Syndrome - TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
Type 2 Diabetes - ConjuChem's PC-DAC(TM):Exendin-4 Lowers Glucose and Weight in Phase II Diabetes Trials
Type 2 Diabetes - MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
Valeant Pharmaceuticals - Valeant Reports Encouraging End of Treatment Results with Taribavirin at Treatment Week 48 in Phase IIb Study
